Rajesh Vijayvergiya

ORCID: 0000-0001-5250-4735 · 1 paper in corpus

article 2025

Danazol causes significant changes in the cardiometabolic profile of patients with acquired aplastic anaemia

·doi:10.1016/j.bcmd.2025.102921

BackgroundDanazol is frequently used in treating patients with acquired aplastic anaemia (AA) in resource-constraint settings. We aimed to evaluate the cardiometabolic side effects of Danazol in patients with AA.MethodsThis prospective stud…